Clinical Immunology Current Events | Clinical Immunology News | 11
|
| Page
11 of
13 |
256 Results |
|
|
|
Sort By:
Page Views | Date |
Genetic tests advertised directly to the consumer
Genetic testing services have recently begun to be advertised directly to the patient, and the results of the consumers' response can affect public health, as well as the future adoption of pharmacogenetic/genomic testing. view more (2009-07-22)
Newly Identified Mechanism Helps Explain Why People of African Descent Are More Vulnerable to Tuberculosis
A team of scientists has identified a cellular mechanism that may help explain the puzzle of why people of African descent are more susceptible to tuberculosis infection and why, once infected, they develop more severe states of the disease than whites. view more (2006-02-27)
Leading toxicologist warns against new drug of abuse
Professor Alison Jones said benzylpiperazine was a "new drug of abuse" which could have serious clinical effects - similar to those of ecstasy to which it is structurally related. view more (2007-04-30)
Study sheds light on causes of HIV dementia
A new study led by researchers at Albert Einstein College of Medicine of Yeshiva University has clarified how two major variants of HIV differ in their ability to cause neurologic complications. view more (2008-12-04)
Retaining our nurses
The sources of stress include: view more (1999-08-20)
Discovery opens door to 'personalized' asthma therapy
In the last few years, "personalized medicine"- using genetic or other molecular biology-based diagnostic tests to customize treatment for a particular patient - has emerged as a powerful new tool for health care. view more (2008-01-18)
Likelihood of a large vCJD epidemic remains small claim researchers
The likelihood of a large number of future cases of vCJD remains small claim researchers from Imperial College London. view more (2005-01-10)
Researchers have discovered a gene that can block the spread of HIV
A team of researchers at the University of Alberta, including a scientist at the University of Pennsylvania, have discovered a gene that is able to block HIV, and thought to in turn prevent the onset of AIDS. view more (2008-02-29)
Oxford Biomedica Plc And Arius Research Inc. Sign Collaborative Programme In Tumour Immunotherapy
Oxford, United Kingdom and Toronto, Canada - 25 July 2002. Oxford BioMedica plc (LSE:OXB) ("BioMedica") and ARIUS Research Inc. ("ARIUS) of Canada announced today a research and development collaboration to search for targets and develop novel products to treat cancer. Under the collaboration ARIUS will supply BioMedica with a... view more... (2002-07-25)
VIAGRA PRESCRIBING WILL BE BASED ON FINANCIAL RATHER THAN CLINICAL REASONING
The secretary of state's proposals for the introduction of sildenafil (Viagra) may be rationing but they are not rational, says Dr John Chisholm in an editorial in this week's BMJ. In dressing up a rationing decision as a clinical one, the secretary of state has ended up with the worst of all possible worlds: a decision that makes no sense on... view more... (1999-01-28)
New drug effective for rheumatoid arthritis, Stanford scientist finds
A new drug appears to offer pain relief and increased mobility to rheumatoid arthritis patients who have exhausted their other medical treatment options. view more (2005-09-15)
Mayo Clinic study finds increased risk of pneumococcal disease in asthma patients
Mayo Clinic research shows adults with asthma are at increased risk of serious pneumococcal disease caused by Streptococcus pneumoniae, the most common bacteria causing middle ear infections and community acquired pneumonia. view more (2008-12-22)
Speed of PSA rise helps predict survival for prostate cancer patients
The clinical outcome for prostate cancer patients who have been treated with hormone therapy and radiation therapy can usually be determined by how rapidly their prostate specific antigen level rises following treatment. view more (2005-10-03)
HBV genotype B/B3 and C/C1 are the major genotypes in Indonesia?
Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial. view more (2009-09-16)
Antioxidant protects against lung damage in silicosis
Levels of heme oxygenase-1 (HO-1), an antioxidant that protects against reactive oxygen species (damaging oxygen molecules that cause direct tissue injury), become elevated in the lungs of chronic silicosis patients and could represent a new treatment approach for the disease. view more (2006-10-16)
Emory study of syphilis bacteria yields valuable diagnostic tool
Variations in a gene within the family of bacteria that causes syphilis may hold clinical, epidemiological and evolutionary significance, researchers at Emory University in Atlanta have found. view more (2008-06-16)
UK approval procedures will drive research overseas
Approval procedures for UK research will "accelerate the migration of clinical studies to other parts of the world," warn researchers in a letter to this week's BMJ. view more (2005-04-06)
Hans Wigzell named America’s Swede of the Year
Professor Hans Wigzell, rector of Karolinska Institutet, Stockholm, and a world leader in immunology, has been chosen by the Swedish Council of America to receive the honorary title of America’s Swede of the Year. view more (2002-09-03)
New hope for hepatitis C sufferers
Adelaide scientists will lead a $2 million five-year project to develop new vaccines and explore better treatment options for hepatitis C sufferers. view more (2008-02-07)
Reducing side effects of painkillers
Cardiff University researchers have increased the understanding of why some painkillers increase the risk of heart attack and stroke. view more (2006-09-13)
|
|
| Page
11 of
13 |
256 Results |
|
|
|
Sort By:
Page Views | Date |
|
